Suchergebnisse - "Lozano, Rebeca"

PubPharm (32)

1

Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223 : The PRORADIUM Study

enthalten in: European urology oncology | 2023

von Romero-Laorden, N. | Lorente, D. | de Velasco, G. | +26

2

Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Lozano, R. | Castro, E. | Lopez-Campos, F. | +29

3

A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide

enthalten in: The Prostate | 2023

von Fernandez-Perez, M. | Perez-Navarro, E. | Alonso-Gordoa, T. | +28

4

Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma

enthalten in: Cancers | 2023

von Parent, P. | Auclin, E. | Patrikidou, A. | +15

5

Implications of DNA damage repair alterations for the management of prostate cancer

enthalten in: Current opinion in urology | 2022

von Lozano, R. | Olmos, D. | Castro, E.

6

Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations

enthalten in: The Prostate | 2021

von Sokolova, A. | Marshall, C. | Lozano, R. | +17

7

Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer : A multicenter biomarker study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Conteduca, V. | Wetterskog, D. | Castro, E. | +17

8

Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients

enthalten in: Cancers | 2021

von Lozano, R. | Lorente, D. | Aragon, I. | +18

9

Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Lozano, R. | Salles, D. | Sandhu, S. | +23

10

Risk Prediction Tools Available for Germline BRCA1/2 Mutations Underperform in Prostate Cancer Patients

enthalten in: European urology oncology | 2021

von Oliva, L. | Lozano, R. | Llácer, C. | +19